COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1455: Articles 14541-14550  | Next

Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
Akashi, Y., Kiyasu, Y., Takeuchi, Y., Kato, D., Kuwahara, M., Muramatsu, S., Ueda, A., Notake, S., Nakamura, K., Ishikawa, H., Suzuki, H.
10.1101/2021.06.09.21258157 — Posted: 2021-06-13
Seasonal variation in SARS-CoV-2 transmission in temperate climates
Gavenciak, T., Monrad, J. T., Leech, G., Sharma, M., Mindermann, S., Brauner, J. M., Bhatt, S., Kulveit, J.
10.1101/2021.06.10.21258647 — Posted: 2021-06-13 Discussion: Onsite
Comprehensive characterization of COVID-19 patients with repeatedly positive SARS-CoV-2 tests using a large US electronic health record database
Dong, X., Zhou, Y., Shu, X.-o., Bernstam, E., Stern, R., Aronoff, D., Xu, H., Lipworth, L.
10.1101/2021.06.10.21256915 — Posted: 2021-06-13
SARS-COV-2 VIRUS INFECTED PATIENT IDENTIFICATION THROUGH CANINE OLFACTIVE DETECTION ON AXILLARY SWEAT SAMPLES
Grandjean, D., Gallet, C., Lecoq-Julien, C., Sarkis, R., Muzzin, Q., Roger, V., Roisse, D., Dirn, N., Levert, C., Breton, E., Galtat, A., Forget, A., Charreaudeau, S., Gasmi, F., Jean-Baptiste, C., Petitjean, S., Hamon, K., Duquesne, J.-M., Coudert, C., Tourtier, J.-P., Billy, C., Wurtz, J.-M., Chauvin, A., Eyer, X., Ziani, S., Prevel, L., Cherubini, I., Khelili-Houas, E., Hausfater, P., Devillier, P., Desquilbet, L.
10.1101/2021.06.10.21257898 — Posted: 2021-06-13
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study
Herzberg, J., Vollmer, T., Fischer, B., Becher, H., Becker, A.-K., Honarpisheh, H., Guraya, S. Y., Strate, T., Knabbe, C.
10.1101/2021.06.09.21258648 — Posted: 2021-06-13
Modeling and reviewing analysis of the COVID-19 epidemic in Algeria with diagnostic shadow
Jia, J., Liu, S., Liu, Y., Shan, R., Zennir, K., Zhang, R.
10.1101/2021.06.09.21258668 — Posted: 2021-06-13
Early evidence for the safety of certain COVID-19 vaccines using empirical Bayesian modeling from VAERS
von Csefalvay, C.
10.1101/2021.06.10.21258589 — Posted: 2021-06-13
Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through AI and machine learning: Application to COVID-19 related pharmacovigilance
Xu, X., Kawakami, J., Indika Millagaha Gedara, N., Riviere, J., Meyer, E., Wyckoff, G. J., Jaberi-Douraki, M.
10.1101/2021.06.07.21258497 — Posted: 2021-06-12
MicroRNA-based regulation of genomics and transcriptomics of inflammatory cytokines in COVID-19
Khokhar, M., Tomo, S., Purohit, P.
10.1101/2021.06.08.21258565 — Posted: 2021-06-12
Inequalities in healthcare disruptions during the Covid-19 pandemic: Evidence from 12 UK population-based longitudinal studies
Maddock, J., Parsons, S., Di Gessa, G., Green, M. J., Thompson, E. J., Stevenson, A. J., Kwong, A. S. F., McElroy, E., Santorelli, G., Silverwood, R. J., Captur, G., Chaturvedi, N., Steves, C. J., Steptoe, A., Patalay, P., Ploubidis, G. B., Katikireddi, S. V.
10.1101/2021.06.08.21258546 — Posted: 2021-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).